FEMY News

The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL) priced at the midpoint to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and...read more

Femasys, which develops women's healthcare-focused medical products and devices, raised $34 million by offering 2.7 million shares at $13, within the range of $12 to $14. Certain insiders had indicated on $17.5 million worth of shares in the offering. Femasys is focused on transforming women's healthcare by developing novel solutions and next-generation advancements to address...read more

Femasys, which develops women's healthcare-focused medical products and devices, announced terms for its IPO on Monday. The Suwanee, GA-based company plans to raise $34 million by offering 2.7 million shares at a price range of $12 to $14. Certain insiders intend to purchase up to an aggregate of $17.5 million worth of shares in the offering. At the midpoint of the proposed...read more

Updated Monday, 6/14. 15 IPOs are currently slated to raise $2.5 billion in the week ahead, led by a preclinical biotech being valued at $4.7 billion. The largest deal of the week, Lyell Immunopharma (LYEL) plans to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and epigenetic reprogramming to develop T...read more